|
|
||||||||
Ann Thorac Surg 2001;72:1473-1478
© 2001 The Society of Thoracic Surgeons
a Department of Cardiovascular Surgery, Osaka National Hospital, Osaka, Japan
Accepted for publication June 13, 2001.
* Address reprint requests to Dr Isobe, Department of Cardiovascular Surgery, Osaka National Hospital, 2-1-14 Hoenzaka, Chuo-ku, Osaka, 540-0006, Japan
e-mail: isobe{at}onh.go.jp
| Abstract |
|---|
|
|
|---|
Methods. Forty-six patients with chronic atrial fibrillation who underwent the BAP-maze procedure were compared with 40 patients who underwent the maze III procedure. The ratio of the peak velocity of the A and E waves of transmitral flow (transthoracic pulsed Doppler echocardiography), the left atrial appendage ejection fraction (transesophageal echocardiography), and the atrial natriuretic peptide secretory reserve during treadmill exercise test were measured at 6 months postoperatively.
Results. Sinus rhythm was restored in 44 patients (95.7%) by the BAP-maze procedure and in 39 patients (97.5%) by the maze III procedure. The ratio of the peak velocity of the A and E waves was 0.52 ± 0.22 in the BAP-maze group and 0.25 ± 0.19 in the maze III group (p < 0.0001). The left atrial appendage ejection fraction was 44.7% ± 11.5%, and the atrial natriuretic peptide secretory reserve was greater in the BAP maze group (p = 0.037).
Conclusions. The BAP-maze procedure improved atrial transport and atrial natriuretic peptide secretion as well as simplifying the maze operation, without decreasing its effectiveness against atrial fibrillation.
| Introduction |
|---|
|
|
|---|
Therefore, we developed a new procedure named the bilateral appendage-preserving maze procedure (BAP-maze) to improve atrial transport, maintain ANP secretion, and simplify the maze procedure without reducing its effectiveness against AF.
| Patients and methods |
|---|
|
|
|---|
70% or left atrial systolic dimension
80 mm) should be excluded from the maze operation [3], but there was no patient who met this exclusion criterion in the present series.
Bilateral appendage-preserving maze procedure
In the BAP-maze procedure, both atrial appendages are kept intact and three incisions are eliminated from the original maze III procedure: one between the pulmonary vein isolation line and the orifice of the left atrial appendage, one between the tricuspid annulus and the orifice of the right atrial appendage, and one on the right atrial free wall from the right atrial appendage orifice (Fig 1A, 1C). The remainder of the operation is the same as the maze III procedure.
|
As the postoperative anticoagulation protocol to prevent thromboembolism, we administer coumadin and try to control the patients international normalized ratio at 2 to 3 as soon as possible after the cessation of bleeding. Treatment is usually started on the first postoperative day, if the patient can take medicine orally. If oral intake is impossible, the activated coagulation time is maintained at up to 150 seconds with heparin. Anticoagulation is continued until 3 months postoperatively as in the case of mitral valvuloplasty.
The present study investigated the BAP-maze procedure and evaluated its efficacy against AF to determine the necessity for atrial appendectomy as a component of the maze procedure. We also compared postoperative atrial transport and ANP secretion after the BAP-maze and maze III procedures.
Data acquisition
We reviewed the electrocardiograms obtained on discharge and once every month postoperatively and assessed whether or not the patients were on antiarrhythmic drugs. At 6 months postoperatively, we measured the A and E wave velocity of transmitral flow (TMF) and transtricuspid flow (TTF) by transthoracic pulsed Doppler echocardiography and also measured the left atrial appendage ejection fraction (LAA-EF) by transesophageal echocardiography. Furthermore, we evaluated the ANP secretory reserve using a treadmill exercise test. Forty patients who underwent the maze III procedure before we started the BAP-maze method were used as controls; mitral valve operation was performed in 38 patients (valvuloplasty in 14), coronary artery bypass graft operation in 1 patient, and atrial septal defect closure in 1 patient. We excluded 3 patients who met the exclusion criterion mentioned above. The 20 men and 20 women ranged from 32 to 72 years old (57.1 ± 10.0 years), and the duration of AF ranged from 4 months to 30 years (6.31 ± 5.97 years). The cardiothoracic ratio ranged from 49% to 71% (59.5% ± 5.5%), and left atrial systolic dimension ranged from 38 to 76 mm (56.6 ± 9.5 mm). Only the left atrial systolic dimension was significantly different from that of the BAP-maze group (p = 0.0007).
Statistical analysis
Continuous variables were compared using the Mann-Whitney U test. Statistical analysis was performed with a StatView J-5.0 software package (Abacus Concepts, Inc, Berkeley, CA).
| Results |
|---|
|
|
|---|
A 68-year-old man from the BAP-maze group had lone AF with a huge thrombus in the left atrial appendage and a history of old cerebral infarction preoperatively. He suffered a small cerebral infarct while in SR on postoperative day 4 and developed left hemiparesis, but this recovered completely after 1 month. We routinely performed anticoagulation for 3 months postoperatively after both procedures, but anticoagulation was extraordinarily inadequate at the time of the embolic event in this patient. The other patients had no embolic events postoperatively.
The cardiac arrest time ranged from 78 to 205 minutes (129.3 ± 28.8 minutes) and the cardiopulmonary bypass time was from 127 to 242 minutes (184.7 ± 32.8 minutes) in the BAP-maze group, whereas the respective values were 79 to 229 minutes (147.6 ± 34.5 minutes) and 136 to 305 minutes (224.1 ± 45.9 minutes) in the maze III group. As expected, both times were significantly shorter in the BAP-maze group than those in the maze III group (p = 0.0071 for the arrest time and p = 0.0001 for the cardiopulmonary bypass time).
Postoperative rhythm
Among the 46 patients in the BAP-maze group, SR was restored in 44 patients (95.7%), whereas AF persisted in 1 patient and AF or atrial tachycardia was seen in 1 patient. Among the 40 patients in the maze III group, SR was restored in 39 patients (97.5%) and AF persisted in 1 patient. The AF conversion rate showed no significant difference between the two groups. During the follow-up period, AF or atrial flutter recurred in 1 patient from the BAP-maze group and 5 patients from the maze III group, but antiarrhythmic medications were effective for restoring SR in all patients.
Three patients from the maze III group developed sick sinus syndrome (paroxysmal junctional bradycardia) that required pacemaker implantation, but no patient from the BAP-maze group needed a pacemaker.
Postoperative atrial transport
To evaluate postoperative atrial transport in the patients who were converted to SR, we assessed the A and E waves of TMF and TTF by transthoracic pulsed Doppler echocardiography at more than 6 months after operation. We could obtain data from 38 patients in the BAP-maze group and all 40 patients in the maze III group. An A wave was detected during TMF and TTF in all 38 patients from the BAP-maze group, whereas it was found in 29 of 40 patients (72.5%) during TMF and 38 of 40 patients (95%) during TTF from the maze III group. The ratio of the peak velocity of the A and E waves (A/E ratio) ranged from 0.25 to 1.14 (0.52 ± 0.22) for TMF and from 0.25 to 1.44 (0.65 ± 0.25) for TTF in the BAP-maze group, whereas it was from 0 to 0.67 (0.25 ± 0.19) for TMF and from 0 to 0.95 (0.53 ± 0.19) for TTF in the maze III group, showing a significant difference (p < 0.0001 for TMF and p = 0.0468 for TTF). Atrial transport was not normalized in either group, but the BAP-maze group showed much better transport than the maze III group (Fig 2).
|
|
|
|
| Comment |
|---|
|
|
|---|
On transthoracic pulsed Doppler echocardiography at more than 6 months postoperatively, A waves were detected during TMF and TTF in all patients from the BAP-maze group versus 72.5% during TMF and 95% during TTF in patients of the maze III group. The A/E ratios of TMF and TTF in the BAP-maze group were superior to those in the maze III group, with a significant difference (p < 0.0001 for TMF and p = 0.0468 for TTF; Fig 2). Both the pattern of atrial conduction and the atrial contraction sequence are more physiologic after the BAP-maze procedure than after the maze III procedure, so the BAP-maze group showed much better atrial transport for ventricular filling than the maze III group because of the contribution of atrial appendage contraction as well as the physiologic conduction and contraction sequence of the both atria.
The left atrial appendage showed good contraction with an LAA-EF of 44.7% ± 11.5% at 6 months after the BAP-maze procedure (Fig 3). Hwang and coworkers [11] reported that the LAA-EF was 58.1% ± 17.4% in normal subjects and 29.5% ± 15.0% in patients with rheumatic mitral valve disease in SR. The LAA-EF measured after the BAP-maze procedure was close to normal and between that of the groups reported by Hwang and associates [11] (Fig 4).
As another function of the atrial appendage, it was reported that it might play an important role as a reservoir to protect against atrial pressure increases [5, 12, 13]. The left atrial appendage is more compliant than the left atrial main chamber, because there is a greater increase of the left atrial appendage dimension than that of the main chamber in response to left atrial volume overload and it might improve left atrial reservoir function under physiologic conditions by protecting the pulmonary capillary system from pressure increases. Therefore, the left atrium could also play a greater role as a reservoir to assist left ventricular filling after the BAP-maze procedure than after the maze III procedure.
One of the early postoperative complications of the maze procedure is fluid retention. Yoshihara and colleagues [14] reported that preservation of the right atrial appendage was effective for improving this complication. When a treadmill test was done at 6 months postoperatively, we found that the ANP level at rest and after exercise showed no significant difference (p = 0.782, and p = 0.175, respectively) between the BAP-maze and maze III groups. This might have been because the exercise load was not the same for all patients. However, delta ANP (the secretory reserve during exercise) was significantly greater in the former group (p = 0.035; Fig 5). As expected, the ANP secretory reserve was maintained in the BAP-maze group by preservation of both atrial appendages, because the right and left atrial appendages are the main source of ANP.
Concerning whether it is better or necessary to preserve both atrial appendages rather than one appendage, there have been several important reports that the left and right atria release ANP independently of each other depending on the stimulus [15, 16]. Also, to improve not only ANP secretion but also atrial transport, bilateral preservation of the atrial appendages should be the aim rather than unilateral preservation.
Because appendectomy and three incisions are eliminated in the BAP-maze procedure (Fig 1A), we could shorten the cardiac arrest time and the cardiopulmonary bypass time by simplifying the maze operation.
One of the drawbacks of any maze procedure, including the BAP-maze procedure, is electrical and mechanical isolation of the posterior left atrium between the pulmonary vein orifices. To preserve this area, Nitta and associates [17] have developed the radial incision approach. However, because they had to perform cryoablation of the four pulmonary vein orifices because ectopic beats in the pulmonary veins could initiate AF [9, 10], there may be no significant hemodynamic improvement over the BAP-maze procedure with regard to left atrial posterior wall contraction. Furthermore, pulmonary vein isolation, as performed in the maze procedures, is more reliable than cryothermia for excluding arrhythmogenic foci in the four pulmonary veins.
The ultimate goal of surgical treatment for AF is to reduce the risk of systemic thromboembolism. Cox and colleagues [18] said that the ability of the maze procedure to decrease the risk of stroke associated AF was probably related to the restoration of SR and atrial transport in combination with removal or obliteration of the left atrial appendage. Several studies have shown that thrombus formation and peripheral embolization in AF patients are related to left atrial appendage dysfunction [19, 20]. We found that the LAA-EF after the BAP-maze procedure was much greater than in patients with rheumatic mitral valve disease in SR, so the presence of the atrial appendage itself should not be a risk factor for thromboembolism (Figs 3, 4). Unfortunately, we experienced one patient who had an embolic episode on postoperative day 4 because of inadequate anticoagulation. We routinely performed anticoagulation for 3 months postoperatively with coumadin in every patient, because there is the possibility of thrombus formation at the suture line in the early postoperative period when the endothelium is damaged and a thrombogenic surface exists at this site. To determine whether the preserved appendage is a source of emboli or not, we need to study more patients for a longer follow-up period.
In conclusion, our data indicated that the BAP-maze procedure could improve atrial transport and ANP secretion as well as simplifying the maze operation without reducing its effectiveness against AF. These results support our hypothesis that appendectomy is not a necessary component of the maze procedure.
| Acknowledgments |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
F. Sacher, J.-B. Corcuff, P. Schraub, V. Le Bouffos, A. Georges, S. O. Jones, S. Lafitte, P. Bordachar, M. Hocini, J. Clementy, et al. Chronic atrial fibrillation ablation impact on endocrine and mechanical cardiac functions Eur. Heart J., May 2, 2008; 29(10): 1290 - 1295. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Takahashi, M. D. O'Neill, M. Hocini, P. Reant, A. Jonsson, P. Jais, P. Sanders, T. Rostock, M. Rotter, F. Sacher, et al. Effects of Stepwise Ablation of Chronic Atrial Fibrillation on Atrial Electrical and Mechanical Properties J. Am. Coll. Cardiol., March 27, 2007; 49(12): 1306 - 1314. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kamohara, Z. B. Popovic, M. Daimon, M. Martin, Y. Ootaki, M. Akiyama, F. Zahr, F. Cingoz, C. Ootaki, M. W. Kopcak Jr, et al. Impact of left atrial appendage exclusion on left atrial function J. Thorac. Cardiovasc. Surg., January 1, 2007; 133(1): 174 - 181. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Melby, S. L. Gaynor, J. G. Lubahn, A. M. Lee, P. Rahgozar, S. D. Caruthers, T. A. Williams, R. B. Schuessler, and R. J. Damiano Jr Efficacy and safety of right and left atrial ablations on the beating heart with irrigated bipolar radiofrequency energy: A long-term animal study J. Thorac. Cardiovasc. Surg., October 1, 2006; 132(4): 853 - 860. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Barnett and N. Ad Surgical ablation as treatment for the elimination of atrial fibrillation: A meta-analysis J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 1029 - 1035. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Halkos, J. M. Craver, V. H. Thourani, F. Kerendi, J. D. Puskas, W. A. Cooper, and R. A. Guyton Intraoperative Radiofrequency Ablation for the Treatment of Atrial Fibrillation During Concomitant Cardiac Surgery Ann. Thorac. Surg., July 1, 2005; 80(1): 210 - 216. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-J. Baek, S.-S. Oh, C.-H. Lee, and C.-Y. Na Outcome of the modified maze procedure for atrial fibrillation combined with rheumatic mitral valve disease using cryoablation Interactive CardioVascular and Thoracic Surgery, April 1, 2005; 4(2): 130 - 134. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Golovchiner, A. Mazur, A. Kogan, B. Strasberg, Y. Shapira, M. Fridman, J. Kuzniec, B. A. Vidne, and E. Raanani Atrial Flutter After Surgical Radiofrequency Ablation of the Left Atrium for Atrial Fibrillation Ann. Thorac. Surg., January 1, 2005; 79(1): 108 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Gaynor, Y. Ishii, M. D. Diodato, S. M. Prasad, K. M. Barnett, N. R. Damiano, G. D. Byrd, S. A. Wickline, R. B. Schuessler, and R. J. Damiano Jr Successful Performance of Cox-Maze Procedure on Beating Heart Using Bipolar Radiofrequency Ablation: A Feasibility Study in Animals Ann. Thorac. Surg., November 1, 2004; 78(5): 1671 - 1677. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Stollberger, B. Schneider, and J. Finsterer Elimination of the Left Atrial Appendage To Prevent Stroke or Embolism?: Anatomic, Physiologic, and Pathophysiologic Considerations Chest, December 1, 2003; 124(6): 2356 - 2362. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. T Sie, W. P Beukema, A. Elvan, and A. R Ramdat Misier New strategies in the surgical treatment of atrial fibrillation Cardiovasc Res, June 1, 2003; 58(3): 501 - 509. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kondo, K. Takahashi, M. Minakawa, and K. Daitoku Left atrial maze procedure: a useful addition to other corrective operations Ann. Thorac. Surg., May 1, 2003; 75(5): 1490 - 1494. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Guden, B. Akpinar, I. Sanisoglu, E. Sagbas, and O. Bayindir Intraoperative saline-irrigated radiofrequency modified Maze procedure for atrial fibrillation Ann. Thorac. Surg., October 1, 2002; 74(4): S1301 - 1306. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |